Viemed Healthcare (VMD) Current Deferred Revenue (2018 - 2026)

Viemed Healthcare has reported Current Deferred Revenue for 9 years, with the latest figure at $7.5 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 10.07% year-over-year to $7.5 million; the trailing twelve-month figure through Mar 2026 stood at $7.5 million (up 10.07% YoY), and the FY2025 full-year result was $7.5 million, up 12.34% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $7.5 million, down from $7.5 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $7.8 million in Q3 2025, with the low at $3.9 million in Q1 2022.
• Historically, Current Deferred Revenue has averaged $6.1 million across 5 years, with a median of $6.2 million in 2023.
• Annual changes were most pronounced in 2023 — Current Deferred Revenue surged 35.39% — and 2025, when it advanced 6.99%.
• Viemed Healthcare's Current Deferred Revenue stood at $4.6 million in 2022, then surged by 34.23% to $6.2 million in 2023, then increased by 7.85% to $6.7 million in 2024, then gained by 12.34% to $7.5 million in 2025, then decreased by 0.55% to $7.5 million in 2026.
• The last three Current Deferred Revenue figures came in at $7.5 million (Q1 2026), $7.5 million (Q4 2025), and $7.8 million (Q3 2025), per Business Quant data.